Insulin Access and Health Outcomes After the Inflation Reduction Act’s Out-of-Pocket Spending Caps
Автор: Emory Global Diabetes Research Center
Загружено: 2025-12-20
Просмотров: 584
Join us as Dr. Rebecca Myerson shares how public policy shapes access to essential medications and health outcomes, with a focus on insulin affordability following the Inflation Reduction Act’s out-of-pocket spending caps. Drawing on rigorous econometric methods and large-scale Medicare data, she shares early findings on cost savings, insulin use, adherence, and persistent implementation gaps, while highlighting implications for equity, policy enforcement, and future health system responses.
About Dr. Rebecca Myerson:
Dr. Rebecca Myerson is a Professor in the Department of Health Policy and Management at Emory University’s Rollins School of Public Health. She holds a PhD in Public Policy from the University of Chicago, an MPH in Health Metrics and Evaluation from the University of Washington, and a bachelor’s degree in Psychology from Harvard University. Her research focuses on how public policies influence health insurance coverage, access to care, medication affordability, and health outcomes. Dr. Myerson’s work has been published in leading journals, including JAMA, Health Affairs, and Social Science & Medicine, and featured in major media outlets such as The Washington Post, CNN, and Bloomberg News.
About EGDRC: diabetes.emory.edu
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
